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Abstract
Objective Next-generation sequencing is increasingly utilizedworldwide as a research and diagnostic tool and is anticipated to be
implemented into everyday clinical practice. Since Central-Eastern European attitude toward genetic testing, especially broad
genetic testing, is not well known, we performed a survey on this issue among Hungarian participants.
Methods A self-administered questionnaire was distributed among patients and patient relatives at our neurogenetic outpatient
clinic. Members of the general population were also recruited via public media. We used chi-square testing and binary logistic
regression to examine factors influencing attitude.
Results We identified a mixed attitude toward genetic testing. Access to physician consultation positively influenced attitude. A
higher self-determined genetic familiarity score associatedwith higher perceived genetic influence score, which in turn associated
with greater willingness to participate in genetic testing. Medical professionals constituted a skeptical group.
Conclusions We think that given the controversies and complexities of the next-generation sequencing field, the optimal clinical
translation of NGS data should be performed in institutions which have the unique capability to provide interprofessional health
education, transformative biomedical research, and crucial patient care. With optimization of the clinical translational process,
improvement of genetic literacy may increase patient engagement and empowerment.
Relevance of the article for predictive, preventive, and personalized medicine The paper highlights that in countries with
relatively low-genetic literacy, a special strategy is needed to enhance the implementation of personalized medicine.
Keywords Next-generation sequencing . Hungary . Survey . Counseling . Ethic . Predictive genetic tests . Predictive preventive
personalizedmedicine . Direct to consumer genetic tests . Genetic literacy
Background
Understanding genetics is an especially important factor
in predictive, preventive, and personalized medicine
(PPPM) [1]. In recent years, next-generation sequencing
(NGS) has become increasingly utilized worldwide as a
genetic research and diagnostic tool [2, 3]. The introduc-
tion of this technique in the study of human diseases has
made the diagnosis of many diseases easier and faster [4].
However, the rapid spread of this technology has also
raised many questions from a regulatory and ethical point
of view. Clinical geneticists face the problem of reporting
and interpreting a large amount of information on a great-
er scale than ever before [5]. Direct-to-consumer testing is
available in many countries, which also raises questions
about the role and method of genetic counseling before
and after these services. Because next-generation sequenc-
ing can generate many potential output, preparing patients
before actual testing is complex. The quantitative change
in the magnitude of genetic results may also mean a qual-
itative change from an ethical point of view [6]. Many
important questions have been raised in the literature re-
garding genetic counseling and next-generation sequenc-
ing technologies in recent years, such as reporting inci-
dental findings [3] and reporting variants of uncertain
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significance [7]. Further problems arise from the blurring
line between research and clinical practice [8] and the
necessity of reanalysis of results [9]. Sharing genetic test
results among researchers and with the patient’s family
members raises questions [10]. Additionally, special cir-
cumstances may arise when children are involved in NGS
studies [11]. Based on a non-systemic search of the liter-
ature available in PubMed, attitudes toward genetic test-
ing and opinions on the abovementioned questions have
not been previously assessed in detail in Central-Eastern
European countries (as defined by OECD). As next-
generation sequencing is increasingly available in this part
of Europe, it is critical to collect opinions on these issues.
Methods
Instrumentation
The survey was distributed in Hungarian language. It con-
tains 37 questions (Q1-Q37) with 72 items (42 single
choice, six open-ended, three multiple choice, 21 rating
scale). The survey was broken up into five parts. The first
part asks for the respondent’s sociodemographic informa-
tion. The second part focuses on genetic knowledge and
concepts in genetics. The third part asks questions about
attitudes toward ordering genetic tests. The fourth part
inquires about genetic test results and incidental findings,
and the fifth part is about sharing genetic test results as
well as genetic material.
We created two scoring systems from items in ques-
tions Q10 and Q12 for further analysis. Question 10
asked the respondents to read nine phrases and rate
how well she or he understands the given phrase on a
1–10 scale (score 10 if totally understood, score 1 if not
understood at all). We summed the scores from these
nine phases, so that a total score ranges from 10 to
90. We named this summary score Bself-rated genetic
familiarity score.^ We did not adopt previously used
objectives and perceived genetic knowledge measures
[12–15] because the purpose of this study was to mea-
sure the respondent’s familiarity with the phrases used
frequently in relation to the subject.
Question 12 asked respondents to rate on a scale of
1–4 how much a given trait is influenced by genetics in
their viewpoint (1, no effect at all; 2, slight effect; 3,
strong effect; 4, completely determined by genetics).
Some of the traits in question are scientifically known
to be influenced strongly or determined completely by
genetics, but some of the traits are more controversial.
We decided not to take into consideration whether re-
sponses were correct or incorrect; instead, we summed
the scores for these ten questions, which we named the
Bperceived genetic influence score.^ This score ranges
from 10 to 40. We used a cutoff score of 30 to create
two groups of respondents for further statistical hypoth-
esis testing. A score of 30 or above means that a re-
spondent rated all the traits as influenced strongly or
determined completely by genetics.
Participants
We distributed the paper-based survey to patients and patient’s
relatives at our neurogenetic outpatient clinic. The same ver-
sion of the questionnaire was available online, and the web
link to the questionnaire was sent out by email to patients who
had previously provided their email addresses to us. The web
link to the questionnaire was also shared on social media. The
survey was distributed among medical students who attended
our genetic lectures, as well as the general population who
attended our annual open lecture for those interested in genetic
science. The study was approved by an institutional ethical
committee (Semmelweis University Regional and
Institutional Committee of Science and Research Ethics, SE
TUKEB 194/2015). The questionnaire started with an in-
formed consent about the survey. Consent was given by filling
out the survey because the survey was anonymous.
Data analysis
We used IBM-SPSS 21.0 for Windows for all analyses.
Individuals refusing to answer specific questions were ex-
cluded only from evaluation of the question concerned.
Prevalence was measured as a percentage. Binary data
(either as collected or collapsed) was analyzed using the
chi-square test and binary logistic regression analysis with
odds ratios (ORs) with 95% CIs at a significance level of
p < 0.05. The influence of education and profession
(health related or not) on the self-rated genetic familiarity
score was determined using the Kruskal-Wallis test and
Mann-Whitney U test, respectively. The Mann-Whitney
U test was also used to determine if the distribution of
the self-rated genetic familiarity score was the same
across respondents with perceived genetic influence score
above 30 or under 30. To assess predictors for positive
attitude toward direct to consumer (DTC) testing, a mul-
tivariate binary logistic regression model was used for
three questions, which were identified as relevant ques-
tions for DTC testing: (1) Q16: Do you think it is accept-
able to have the opportunity to purchase genetic tests
commercially? (2) Q18: Would you ask for comprehen-
sive genetic testing just out of curiosity? (3) Q19.4:
Would you ask for a genetic test if you are in good health,
without a medical consultation in order to learn about
your ancestry for curiosity?
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Results
Respondents
In total, 657 people filled out the survey (463 female,
177 male, 17 people did not indicate their gender). Five
hundred fifty-nine people filled out the survey
completely. Mean age of the respondents was 41 ±
14.6 years (41.6 ± 14.8 for males and 40.89 ± 14.49 for
females). 49.2% of the respondents had either a univer-
sity or college degree. Seventy-two respondents worked
in healthcare (28 of which were physicians), and 14
respondents studied a healthcare-related profession (11
of which were medical students). 47% of the respon-
dents are from the capital city, Budapest.
Self-rated genetic familiarity score
The distribution of the self-rated knowledge score is
represented in Fig. 1. Mean score was 64.96 ± 22.38.
The self-rated familiarity score was significantly higher
among respondents who worked in healthcare (Mann-
Whitney U p < 0.01) compared to respondents not work-
ing or studying in a healthcare-related profession and
was significantly higher with higher educational status
(Kruskal-Wallis p < 0.01) (Table 1). There was no cor-
relation with age (Spearman’s rho: − 0.040).
Perceived genetic influence score
Responses on perceived genetic influence are represented
in Fig. 2. The total score ranged from 1 to 40. One hundred
nine people (18.5%) had a score greater than or equal to the
cutoff value of 30 (a score of 3 or 4 on all the questions).
Respondents with a greater self-rated genetic familiarity
score were more likely to have high-perceived genetic in-
fluence (Mann-Whitney U p = 0.007). Respondents with a
high-perceived genetic influence score were more likely to
ask for whole genome testing (with or without medical
consultation option) for later use than those with a per-
ceived genetic influence score below 30 [49 (48.5%) vs
172 (37.7%) p = 0.056; 63 (63.6%) vs 231 (50.9%) p =
0.026, respectively]. Respondents with a high score were
also more likely to request genetic testing with consulta-
tion to detect common risk modifier variants [87 (87.0%)
vs 335 (73.1%) p = 0.003] or if a serious but manageable
disease might be discovered, even if they are currently
healthy [99 (97.1%) vs 396 (85.9%) p = 0.001].
Fig. 1 Distribution of self-rated
genetic familiarity scores.
Legend: Frequency of self-rated
genetic familiarity scores divided
by five points. High scores were
relatively frequent, which could
be explained by the
overrepresentation of respondents
with college or university degrees
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Factors influencing attitude toward genetic testing
and related questions
Bivariate analyses
We performed bivariate analyses to investigate the effect of
different demographic parameters on attitude toward genetic
testing, incidental findings, and sharing genetic test results.
Gender, profession, self-rated genetic familiarity, and perceived
genetic influence scores significantly affected more than one
outcome variable as outlined below. Besides these, consultation
with a physician also influenced some of the outcome variables.
GenderMale respondents were more likely to request genetic
testing with or without consulting a medical doctor in some
conditions. This is presented in Table 2. However, a greater
percentage of female than male respondents had a high-
perceived genetic influence score (21.9 vs. 11.4% p = 0.003).
Working in healthcare Healthcare providers and respondents
not working or studying in healthcare differed somewhat in
attitude toward genetic testing. While there was no significant
difference when requesting tests without a physician consul-
tation, there were significant differences when physician con-
sultation was indicated in the question (Table 3).
If respondents are currently healthy but there is potential to
detect a serious untreatable disease, those who are healthcare
workers would less frequently ask for genetic testing com-
pared to non-healthcare workers. There was a marginally sig-
nificant difference between the two groups if a serious but
manageable disease might be discovered [40 (54.1%) vs 310
(70.5%) p = 0.007; 60 (80.0%) vs 387 (88.6%) p = 0.058].
Consultation with a physician The opportunity to consult with
a doctor increases motivation to participate in genetic testing
in multiple ways (Table 4). Significant differences were pres-
ent in motivation for detecting rare diseases, screening for
serious diseases, and screening for common risk variants and
for later use in whole genome analysis. Interest in ancestry and
certain physiological features remained low regardless of the
option of consultation with physician.
Predictors for a positive attitude toward direct to consumer
genetic testing
The results of the logistic regression are presented in Table 5. Age
and gender had the greatest influence on attitude toward genetic
testing. Male respondents were more likely to request a genetic
test just for curiosity or for ancestry purposes. Younger respon-
dents were more likely to request a genetic test for medical pur-
poses and participate in commercially available genetic testing.
Table 1 Self-rated genetic familiarity score with different educational
status
Educational status N Mean 95% confidence
interval for mean
Vocational training 20 45.35 32.78–57.92
Middle school 26 50.04 40.84–59.24
Vocational school 51 61.69 56.10–67.28
High school 141 63.57 59.81–67.32
College 100 64.65 60.43–68.87
University 197 70.21 67.15–73.26
National qualification
registered Training
10 70.80 59.01–82.59
Total 599 64.96 63.17–66.76
Number of respondents (N) with different educational status and the mean
self-rated genetic familiarity score, with 95% confidence intervals.
National qualification registered training is a diverse group of trained
professionals in Hungary. Generally, higher educational status associated
with higher self-rated genetic familiarity score
Fig. 2 Distribution of perceived genetic influence scores. Legend:
Distribution of perceived genetic influence scores on different traits.
Patients were asked to rate on a scale of 1–4 how much a given trait is
influenced by genetics in their viewpoint, where 1 means that a given trait
is not influenced by genetics and 4 is that the trait is totally determined by
genetics. It can be seen that even traits which are biologically determined
by genetic factors (such as eye color) could be perceived as non-genetic,
and complex traits could be perceived as strongly influenced by genetics
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Educational status also affected certain attitudes, but not in a
consequent manner. Respondents who identified themselves as
religious expressed lower acceptance toward commercial genetic
tests, with borderline significance. The model could explain 8.0–
11.0% of total variance for the questions included in the analysis.
Discussion and conclusion
Discussion
Attitude toward genetic testing when in good health
There are a variety of different motives for broad genetic test-
ing when in good health [16]. Health-related motives may
include the potential for early detection and intervention, pre-
vention, and closer monitoring [17]; for adoptees, it can be a
source of familial medical history [18]. Non-health-related
motives may include curiosity, desire to learn ancestry infor-
mation, participation in research, and recreation-related mo-
tives [16].
Our respondents expressed mixed attitudes toward ge-
netic testing when in good health. Health-related tests
were more likely indicated as a motivation for testing,
especially when physician consultation was an option.
After consulting a physician, 73.5% of the respondents
would request a genetic test to screen for genetic de-
fects causing serious diseases, and 65.3% would ask for
a genetic test to detect genetic risk factors for common
diseases. Without a consultation, only 47.6 and 46.9%
Table 2 Differences between
male and female respondents in
motives for genetic testing when
in good health
Male Female P value
Q19. Would you ask genetic test without
consulting a doctor in a healthy condition for
4. Interest in ancestry 84 (51.5%) 149 (38.9%) 0.008
5. Determine certain body features 60 (36.8%) 69 (18.2%) < 0.001
6. Whole genome for future use 85 (51.2%) 135 (35.0%) < 0.001
Q20. Would you ask genetic test with
consulting a doctor in a healthy condition for
3. Gene defects that slightly increase the
possibility of common diseases
131 (81.2%) 282 (73.2%) 0.051
4. Interest in ancestry 90 (54.5%) 145 (38.4%) 0.001
5. Determine certain body features 63 (38.2%) 81 (21.5%) < 0.001
6. Whole genome for later use 105 (63.6%) 186 (48.8%) 0.002
Number of respondents and percentages (in parentheses) of male and female respondents who answered Byes^ for
the given questions. Only significant differences were included in the table. For certain motives, male respondents
had more positive attitudes toward testing
Table 3 Differences in genetic
attitude of respondents employed
in healthcare and non-healthcare-
related fields
Healthcare
respondents
Non-healthcare
respondents
P value
Q19. Would you ask genetic test without
medical consultation in a healthy condition for
1. Define the risk for certain rare diseases 30 (41.1%) 213 (48.4%) 0.257
2. Find out gene defects causing serious diseases 33 (45.2%) 242 (55.0%) 0.13
3. Gene defects that slightly increase the possibility
of common diseases
35 (47.3%) 237 (54.0%) 0.315
4. Interest in ancestry 31 (41.9%) 185 (43.0%) 0.899
5. Determine certain body features 16 (21.6%) 110 (25.7%) 0.561
6. Whole genome for later use 22 (30.1%) 178 (40.7%) 0.093
Q20. Would you ask genetic test with medical
consultation in a healthy condition for
1. Define the risk for certain rare diseases 46 (61.3%) 351 (80.1%) 0.001
2. Find out gene defects causing serious diseases 54 (72.0%) 372 (85.1%) 0.007
3. Gene defects that slightly increase the possibility
of common diseases
46 (62.2%) 339 (78.3%) 0.005
4. Interest in ancestry 30 (41.1%) 188 (43.7%) 0.703
5. Determine certain body features 18 (24.3%) 121 (28.3%) 0.574
6. Whole genome for later use 31 (41.9%) 234 (54.4%) 0.058
Number of respondents and percentages (in parentheses) of those employed in healthcare or non-healthcare fields
who answered Byes^ on the given question. Significant p values are in italics. For question Q20.1, Q20.2, and
Q20.3, healthcare workers were significantly less likely to respond positively, while for Q20.6 a marginally
significant difference was detected, which shows a greater interest in genetic test among non-healthcare-related
workers
EPMA Journal (2018) 9:103–112 107
of respondents would request such tests, respectively.
Interest in ancestry information and certain physiologi-
cal features (such as determining eye color from genetic
data) was generally lower regardless of the option for
consultation (36.8% for ancestry information and 22.4%
for physiological features with consultation; 36.5 and
22.4% respectively without consultation). This is differ-
ent from the findings of Baptista et al. in a cohort from
the USA [18], where 80 adoptees and 1527 non-adopted
adults expressed a high interest in ancestry information
(73% of the non-adoptees and 83% of the adoptees
were Bvery interested^ in learning ancestry information).
Although we have no information on the cause of this
discrepancy, we speculate that the different history of
the two countries regarding immigration could give an
explanation.
A mixed attitude was also detected in a hypothetical situa-
tion when a serious genetic disease is present in the family, but
the respondent is healthy. In this case, 51.9% of the respon-
dents would like to know if he or she is carrying the patho-
genic mutation in every case, 9% only if it is treatable, and
15.5% only if the respondent would like to have a child. In a
separate question, we asked if the respondent would like to be
contacted if some genetic findings related to their health
emerge later in a research project. 61.9% would like to be
contacted in every case, 18.1% only if there is a chance to
intervene for the given condition, and 4.9% did not want to
be contacted at all. It has been shown previously in the liter-
ature that disease severity and ability to treat the disease pos-
itively correlated with a positive attitude toward testing [19],
but our respondents expressed a high interest regardless. A
similarly high interest in incidental findings from diagnostic
sequencing was also found in other studies [20].
The concept of direct to consumer testing has changed
somewhat in recent years. Previously, it meant ordering a ge-
netic test and receiving results without clinician involvement,
but nowadays it is viewed more as a spectrum with various
levels of physician involvement [21]. There were directly and
indirectly connected questions on DTC included in our ques-
tionnaire. It was stated by 44.7% of our respondents that it is
acceptable for them to buy genetic tests commercially, and
48.9% stated that she or he would use such service. US-
based studies found a similar rate of potential interest in
DTC genetic testing [22]. There is less information from
European countries on potential consumers for nonspecific
testing. In our cohort, the interest in genetic testing for differ-
ent motives showed that this is mostly relevant for health-
related testing.
Factors influencing attitude toward genetic testing and DTC
testing
Differences between males and females and healthcare and
non-healthcare workers emerged in bivariate analyses.
According to the logistic regression model, age and gender
were the most relevant factors influencing attitudes.
Educational status and religious devotedness also had a mild
effect. Male respondents were more likely to be interested in
genetic testing with or without medical consultation for ances-
try information, to determine certain physiological features,
and whole genome testing for later analysis. They were also
more interested in identifying genetic risk factors for common
Table 4 Differences of attitude
toward testing with availability of
physician consultation
Q19. Without medical
consultation
Q20. With medical
consultation
OR (95% CI) P value
Yes No Yes No
Would you ask genetic testing in a healthy state for
1. Define the risk for
certain rare diseases
277 (48.3) 296 (51.7) 446 (78) 126 (22) 3.78 (2.92–4.89) < 0.001
2. Find out gene
defects causing
serious diseases
313 (54.7) 259 (45.3) 483 (84.3) 90 (15.7) 4.4 (3.36–5.86) < 0.001
3. Gene defects that
slightly increase the
possibility of
common diseases
308 (53.8) 264 (46.2) 429 (75.8) 137 (24.2) 2.7 (2.08–3.45) < 0.001
4. Interest in ancestry 242 (43) 320 (57) 240 (42.9) 319 (57.1) 1 (0.78–1.26) 1
5. Determine certain
body features
134 (24) 425 (76) 147 (26.4) 410 (73.6) 1.1 (0.86–1.49) 0.35
6. Whole genome for
later use
224 (39.5) 343 (60.5) 299 (53.2) 263 (46.8) 1.7 (1.37–2.2) < 0.001
Attitude toward different motives for testing with physician consultation availability. Significant p values are in
italics. The results show that in the case of genetic tests with a clear medical utility, the availability of medical
consultation associates with a greater desire to test
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diseases if medical consultation was an option. However,
fewer male than female respondents had a high-
perceived genetic influence score (11.4 vs. 21.9% p =
0.003). Healthcare workers and students seemed to be
more skeptical toward genetic testing; for almost every
motive, they were less likely to request a genetic test
with medical consultation. We do not think that the
reason for this is that they view themselves as qualified
to request a genetic test and for this reason felt the
medical consultation was unnecessary. Overall, the per-
centage of respondents who would ask for a genetic test
was still increased when medical consultation was an
option, but it was significantly higher for non-
healthcare workers. A likely explanation is that the op-
portunity for medical consultation increased interest in
testing among non-healthcare workers on a greater scale
compared to healthcare workers. The more skeptical
view of genetic professionals was also captured in a
study by Middleton et al. [19]. Other studies have also
shown that more knowledge on genetics may be associ-
ated with a lower perceived benefit of testing [23],
which might reflect a more realistic view of genetic
testing utility. The captured skepticism of physicians
might be explained by the current limitations of genetic
data interpretation and often unclear translation into the
clinical setting. Even in well-defined Mendelian disor-
ders, the diagnostic rate of clinical exome sequencing is
around 30% [24]. Genomic risk prediction in multifac-
torial diseases is an even more complex task and even
with improved prediction models clinical validity and
clinical utility has yet to be proven [25]. One way to
improve the predictive capacity of genomic information
is to capture the complexity of an individual’s biological
system by simultaneous analysis of Bmultiple omes^
(e.g., genome, epigenome, transcriptome, proteome),
and creating a personal omics profile [26]. However,
to gain meaningful clinical information from this multi-
layer data is not trivial. Different multi-omics data inte-
gration methodologies are now available, but the field is
still in development [27].
The effect of age on attitude toward genetic testing is
complex according to the literature. In general, younger
people show a more positive attitude and willingness to
participate in genetic testing [23]; this was supported by
our study as well. However, increasing age might be
associated with greater awareness of genetic testing op-
portunities [28], and younger people may express more
concerns related to testing [29] according to literature.
Perceived genetic influence also affected attitude to-
ward genetic testing, which was mostly noticeable when
the medical utility of the genetic test was less obvious.
Those respondents who had a high-perceived genetic
influence score (≥ 30) were more likely to be interested
in testing for common risk modifier variants and in
submitting samples for whole genome sequencing for
later analysis. Interestingly, a higher percentage of fe-
male than male respondents had a high-perceived genet-
ic influence score (21.9 vs 11.4% p = 0.003), but more
male respondents would request a genetic test for ances-
try purposes, for determining certain physiological fea-
tures, and for whole genome analysis at a later time.
This could be because females are generally more skep-
tical toward genetic testing when the medical utility is
uncertain, but a group of female respondent has a high-
perceived genetic influence score, and they are more
likely to ask these tests. According to previous studies,
men may have a more positive attitude toward testing,
but women may have more knowledge of genetics [23].
It is also noteworthy that respondents with a greater
self-rated genetic familiarity score were more likely to
have a high-genetic influence score, as well as
healthcare workers. However, healthcare workers gener-
ally had a more skeptical view of genetic tests, which
indicate that they see the utility of these tests
differently.
There are some available measures for determining
objective and perceived genetic knowledge as well as
genetic self-efficacy in the literature [12, 15, 30–32].
However, these are heterogeneous and in Hungary there
is no validated measure for determining objective genet-
ic knowledge or self-efficacy currently available.
Instead, we measured familiarity with genetic phrases,
which is different from knowledge but helps estimate
how likely a respondent has heard about issues raised
in the questionnaire. We showed that the familiarity
score was higher among more educated respondents,
similar to genetic literacy, and genetic knowledge [12,
14, 15]. Additionally, healthcare related workers also
had higher genetic familiarity scores in our study.
More knowledge associates with more positive attitude
toward genetics according to literature, but also with
more concerns [15]. However, high familiarity does
not mean high level of knowledge [14]. It has also been
shown that confidence in genetic knowledge may even
decrease after receiving direct-to-consumer personal ge-
nomic test results [12], which might be addressed by
clinical genetic counseling.
Study limitations
One limitation of our study is that most respondents
were well educated. Additionally, the study population
either has a personal connection to a genetic disease, is
interested in genetics, or is a medical professional.
However, according to the literature, individuals seeking
genetic susceptibility testing are usually highly educated
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[33] and have high level of genetic knowledge [12]. It
can also be assumed that people interested in genetics
or those with a personal connection to a genetic disease
are more likely to use such a service [34]. The larger
representation of medical professionals allowed us to
compare the public and medical viewpoint. Response
rate could not be measured, since we do not have an
estimation of the number of people reached through
public media. Objective genetic knowledge was not
measured, because validated measures in Hungary are
still lacking. In future work, it will be important to
validate such a measure in the Hungarian population
and also compare the genetic familiarity score with ob-
jective knowledge. Regarding predictors for a positive
attitude toward DTC testing, 8–11% of the total varia-
tion could be explained by our model, thus other rele-
vant factors need to be identified.
Conclusions and and expert recommendations
In this study, we showed a mixed attitude toward broad
genetic testing in a Hungarian cohort. Interest was
higher for health-related indications and for tests with
more obvious medical utility. Most relevant factors
influencing attitude toward testing were medical educa-
tion, availability of medical consultation, gender, and
age. Respondents with a higher genetic familiarity score
also had a higher perceived genetic influence score,
which in turn positively influenced attitude toward test-
ing with a less clear medical utility. However, medical
professionals who had a high-genetic familiarity score,
constituted a skeptical group, which might be explained
by the current limitations of NGS data interpretation.
Respondents expressed a higher interest in testing if
medical consultation was an option. Previous studies
show that patients prefer to receive genetic information
from physicians they already know [7, 15, 35], but it is
also shown that physicians generally receive limited
training in genetics [36]. Meanwhile, clinical genetic
counseling is becoming more complex [36]. Thus we
advocate for a model where clinical and research use
of next-generation sequencing is linked to clinical
follow-up with the patients, preferentially performed in
institutes with a dual role as genetic research and clin-
ical institutes. This fits into the dynamic model of man-
aging exome and genome sequencing results [37], but
acknowledges that technology is developing rapidly and
public as well as medical professional’s knowledge in
genomics is limited. Our findings are consistent with the
Act ion Plan of the Internat ional Consor t ia of
Personalized Medicine (ICPerMed) [38] which identify
as actionable research activity for the implementation of
the personalized medicine of the following:
1. Introduce curricula reforms to create new models of
genomic-based healthcare for patients and citizens and
broaden the focus on basic and clinical sciences to include
health systems sciences in the education of all healthcare
professionals
2. Build sustainable resources for educating and training cit-
izens, patients, and patient advocates on involvement of
patients and patient organizations across the entire re-
search and development lifecycle of personalized
medicine
3. Develop the tools and modus operandi of a knowl-
edge network for enhancing health (genomic) and
digital literacy
4. Develop and share best practices of patient engagement
approaches for the needs of a variety of European citizens
5. Develop the instruments for the evaluation of the effec-
tiveness and impact of public engagement initiatives in
personalized medicine
Our results serve as a basis for a national roadmap of per-
sonalized medicine regarding citizen’s engagement and pave
the way for action plans to enhance patient engagement and
empowerment.
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